The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Open accessAbstract
Hidradenitis suppurativa is a severe and debilitating dermatologic disease. Clinical management is challenging and consists of both medical and surgical approaches, which must often be combined for best outcomes. Therapeutic approaches have evolved rapidly in the last decade and include the use of topical therapies, systemic antibiotics, hormonal therapies, and a wide range of immunomodulating medications. An evidence-based guideline is presented to support health care practitioners as they select optimal medical management strategies and is reviewed in this second part of the management guidelines. A therapeutic algorithm informed by the evidence available at the time of the review is provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E. P., Revuz, J., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12966 · Cited by 1,093
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Kimball, A. B., Okun, M. M., Williams, D. A., Gottlieb, A. B., Papp, K. A., Zouboulis, C. C., Armstrong, A. W., Kerdel, F., Gold, M. H., Forman, S. B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504370 · Cited by 807
Self-citationHidradenitis suppurativa: A comprehensive review
Alikhan, A., Lynch, P. J., & Eisen, D. B. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.11.911 · Cited by 705
Self-citationCronstein, B. N., Naime, D., & Ostad, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116884 · Cited by 679
Ebell, M. H., Siwek, J., Weiss, B. D., Woolf, S. H., Susman, J., Ewigman, B., & Bowman, M. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.1.59 · Cited by 561
Ebell, M. H., Siwek, J., Weiss, B. D., Woolf, S. H., Susman, J. L., Ewigman, B., & Bowman, M. A. (2004) · PubMed · Cited by 484
Kimball, A. B., Kerdel, F., Adams, D., Mrowietz, U., Gelfand, J. M., Gniadecki, R., Prens, E. P., Schlessinger, J., Zouboulis, C. C., van der Zee, H. H., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-12-201212180-00004 · Cited by 428
Self-citationGrant, A., Gonzalez, T., Montgomery, M. O., Cardenas, V., & Kerdel, F. A. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.06.050 · Cited by 419
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference
Kalb, R. E., Strober, B., Weinstein, G., & Lebwohl, M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.11.906 · Cited by 368
Comprehensive Dermatologic Drug Therapy
Wolverton, S. E. (2020) · Elsevier eBooks · doi:10.1016/c2014-1-02097-2 · Cited by 338
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa
Jemec, G. B. E., & Wendelboe, P. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70272-5 · Cited by 338
Topical Treatment of Hidradenitis Suppurativa with Clindamycin
Clemmensen, O. J. (1983) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1983.tb02150.x · Cited by 270
Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial
Tzanetakou, V., Kanni, T., Giatrakou, S., Katoulis, A., Papadavid, E., Netea, M. G., Dinarello, C. A., van der Meer, J. W. M., Rigopoulos, D., & Giamarellos-Bourboulis, E. J. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.3903 · Cited by 266
Gener, G., Canoui-Poitrine, F., Revuz, J. E., Faye, O., Poli, F., Gabison, G., Pouget, F., Viallette, C., Wolkenstein, P., & Bastuji-Garin, S. (2009) · Dermatology · doi:10.1159/000228334 · Cited by 265
MORTIMER, P. S., DAWBER, R. P. R., GALES, M. A., & MOORE, R. A. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb05740.x · Cited by 259
Comprehensive Dermatologic Drug Therapy
Hsu, S. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.5.703 · Cited by 236
van der Zee, H. H., Boer, J., Prens, E. P., & Jemec, G. B. E. (2009) · Dermatology · doi:10.1159/000228337 · Cited by 222
Mendonça, C. O., & Griffiths, C. E. M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07155.x · Cited by 219
Kromann, C. B., Deckers, I. E., Esmann, S., Boer, J., Prens, E. P., & Jemec, G. B. E. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13090 · Cited by 203
Blok, J. L., Li, K., Brodmerkel, C., Horvátovich, P., Jonkman, M. F., & Horváth, B. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14338 · Cited by 193
Miller, I., Lynggaard, C. D., Lophaven, S., Zachariae, C., Dufour, D. N., & Jemec, G. B. E. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10339.x · Cited by 192
Gupta, A. K. (1990) · Archives of Dermatology · doi:10.1001/archderm.126.3.339 · Cited by 177
Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa
Boer, J., & van Gemert, M. J. P. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70530-x · Cited by 176
Treatment of Hidradenitis Suppurativa With Etanercept Injection
Adams, D. R., Yankura, J. A., Fogelberg, A. C., & Anderson, B. E. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.72 · Cited by 174
Metformin for the treatment of hidradenitis suppurativa: a little help along the way
Verdolini, R., Clayton, N., Smith, A., Alwash, N., & Mannello, B. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04668.x · Cited by 174
Cusack, C., & Buckley, C. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07067.x · Cited by 171
Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa
Join‐Lambert, O., Coignard-Biehler, H., Jaïs, J., Guet‐Revillet, H., Poirée, S., Fraitag, S., Jullien, V., Ribadeau-Dumas, F., Thèze, J., Guern, A. L., et al. (2010) · Dermatology · doi:10.1159/000321716 · Cited by 151
Kraft, J. N., & Searles, G. E. (2007) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2007.00019 · Cited by 131
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa
Nazary, M., van der Zee, H. H., Prens, E. P., Folkerts, G., & Boer, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.047 · Cited by 131
Fardet, L., Dupuy, A., Kérob, D., Levy, A., Allez, M., Bégon, E., Bachelez, H., Morel, P., & Lebbé, C. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.027 · Cited by 128
Giamarellos‐Bourboulis, E. J., Pelekanou, E., Antonopoulou, A., et al. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08372.x · Cited by 124
Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa
Boer, J., & Jemec, G. B. E. (2009) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2009.03377.x · Cited by 123
Dapsone Therapy for Hidradenitis Suppurativa: A Series of 24 Patients
Yazdanyar, S., Boer, J., Ingvarsson, G., Szepietowski, J. C., & Jemec, G. B. E. (2011) · Dermatology · doi:10.1159/000329023 · Cited by 121
An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa
Leslie, K. S., Tripathi, S. V., Nguyen, T. V., Pauli, M. L., & Rosenblum, M. D. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.044 · Cited by 119
Pathophysiology of hidradenitis suppurativa
Hoffman, L. K., Ghias, M. H., & Lowes, M. A. (2017) · Seminars in Cutaneous Medicine and Surgery · doi:10.12788/j.sder.2017.017 · Cited by 118
Self-citationDeckers, I. E., van der Zee, H. H., Boer, J., & Prens, E. P. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.11.017 · Cited by 116
Join‐Lambert, O., Coignard-Biehler, H., Jaïs, J., Delage, M., Guet‐Revillet, H., Poirée, S., Duchatelet, S., Jullien, V., Hovnanian, A., Lortholary, O., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv361 · Cited by 114
Soria, A., Canouï‐Poitrine, F., Wolkenstein, P., et al. (2008) · Dermatology · doi:10.1159/000182261 · Cited by 113
Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series
Riis, P. T., Boer, J., Prens, E. P., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.06.049 · Cited by 110
A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa
Lee, R. A., Dommasch, E. D., Treat, J. R., Kirby, J. S., Chachkin, S., Williams, J., Shin, D. B., Leyden, J. J., Vittorio, C. C., & Gelfand, J. M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.11.898 · Cited by 107
Self-citationPreliminary findings suggest hidradenitis suppurativa may be due to defective follicular support
Danby, F. W., Jemec, G. B. E., Marsch, W. C., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12233 · Cited by 106
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa
Mekkes, J. R., & Bos, J. D. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08332.x · Cited by 105
A Systematic Review of Treatments for Hidradenitis Suppurativa
Lim, H. W. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.1950 · Cited by 103
Long-term Successful Adalimumab Therapy in Severe Hidradenitis Suppurativa
Blanco, R., Martínez-Taboada, V. M., Villa, I., Gonzaléz‐Vela, M. C., Fernández‐Llaca, H., Agudo, M., & González-López, M. A. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.49 · Cited by 90
Interventions for hidradenitis suppurativa
Ingram, J. R., Woo, P.-N., Chua, S., Ormerod, A. D., Desai, N., Kai, A. C., Hood, K., Burton, T., Kerdel, F. A., Garner, S. E., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010081.pub2 · Cited by 89
Hidradenitis suppurativa treated with dapsone: A case series of five patients
Kaur, M. R., & Lewis, H. M. (2006) · Journal of Dermatological Treatment · doi:10.1080/09546630600830588 · Cited by 86
Cyclosporin-responsive hidradenitis suppurativa.
Buckley, D. A., & Rogers, S. (1995) · Europe PMC (PubMed Central) · Cited by 85
Evaluation of isotretinoin treatment of hidradenitis suppurativa
Dicken, C. H., Powell, S. T., & Spear, K. L. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)70199-x · Cited by 83
Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin.
Rose, R. F., Goodfield, M. J. D., & Clark, S. M. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01983.x · Cited by 81
Methotrexate is of limited value in the treatment of hidradenitis suppurativa
Jemec, G. B. E. (2002) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2002.11125.x · Cited by 73
Successful Treatment of Severe Hidradenitis Suppurativa With Anakinra
Zarchi, K., Dufour, D., & Jemec, G. B. E. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5377 · Cited by 73
Management of Recalcitrant Hidradenitis Suppurativa with Ustekinumab
Sharon, V. R., Garcia, M., Bagheri, S., Goodarzi, H., Yang, C., Ono, Y., & Maverakis, E. M. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1229 · Cited by 69
Failure of Anti-Interleukin-1 Therapy in Severe Hidradenitis Suppurativa: A Case Report
van der Zee, H. H., & Prens, E. P. (2013) · Dermatology · doi:10.1159/000343221 · Cited by 65
PREGNANCY AND APOCRINE GLAND DISEASES: HIDRADENITIS, FOX-FORDYCE DISEASE
CORNBLEET, T. (1952) · Archives of Dermatology · doi:10.1001/archderm.1952.01530200016002 · Cited by 65
Huang, C. M., & Kirchhof, M. G. (2017) · Dermatology · doi:10.1159/000477207 · Cited by 53
Long-term efficacy of infliximab in hidradenitis suppurativa
Paradela, S., Rodríguez-Lojo, R., Fernández‐Torres, R., Bermúdez, M. D. P. A., & Fonseca, E. (2012) · Journal of Dermatological Treatment · doi:10.3109/09546634.2012.683767 · Cited by 51
Low-dose systemic corticosteroid treatment for recalcitrant hidradenitis suppurativa
Wong, D., Walsh, S. R., & Alhusayen, R. O. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.06.001 · Cited by 51
Self-citationArmyra, K., Kouris, A., Markantoni, V., Katsambas, A., & Kontochristopoulos, G. (2017) · International Journal of Dermatology · doi:10.1111/ijd.13428 · Cited by 49
Infliximab for the Treatment of Hidradenitis Suppurativa
Fernández-Vozmediano, J. M., & Armario-Hita, J. C. (2007) · Dermatology · doi:10.1159/000102032 · Cited by 47
Failure of treatment of familial widespread hidradenitis suppurativa with isotretinoin
Norris, J. F. B., & Cunliffe, W. J. (1986) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1986.tb00512.x · Cited by 47
Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab
Scheinfeld, N. S. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.01.024 · Cited by 47
Finasteride in Hidradenitis Suppurativa: A "Male" Therapy for a Predominantly "Female" Disease.
Khandalavala, B. N., & Voutsalath, M. (2016) · Europe PMC (PubMed Central) · Cited by 46
Hidradenitis suppurativa: are tumour necrosis factor-α blockers the ultimate alternative?
Brunasso, A. M. G., Delfino, C., & Massone, C. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08735.x · Cited by 45
Hidradenitis Suppurativa in Children and Adolescents: A Review of Treatment Options
Riis, P. T., & Jemec, G. B. E. (2014) · Pediatric Drugs · doi:10.1007/s40272-014-0091-3 · Cited by 45
Two cases of severe hidradenitis suppurativa with failure of anakinra therapy
Menis, D., Maroñas‐Jiménez, L., Delgado‐Márquez, A. M., Postigo‐Llorente, C., & Vanaclocha-Sebastián, F. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13292 · Cited by 42
Management of hidradenitis suppurativa in pregnancy
Perng, P., Zampella, J. G., & Okoye, G. A. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.032 · Cited by 42
Cyclosporine treatment of severe Hidradenitis suppurativa – A case series
Anderson, M. D., Zauli, S., Bettoli, V., Boer, J., & Jemec, G. B. E. (2015) · Journal of Dermatological Treatment · doi:10.3109/09546634.2015.1088128 · Cited by 40
Hidradenitis suppurativa managed with adalimumab.
Yamauchi, P. S., & Mau, N. (2009) · PubMed · Cited by 34
Tursi, A. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.09.010 · Cited by 34
Tan, M. G., Shear, N. H., Walsh, S. R., & Alhusayen, R. O. (2016) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475416659858 · Cited by 27
Self-citationScheinfeld, N. S. (2016) · Dermatology Online Journal · doi:10.5070/d3226031313 · Cited by 26
Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab
Harde, V., & Mrowietz, U. (2009) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2008.06918.x · Cited by 21
Hidradenitis suppurativa-acne inversa: a relevant dermatosis in paediatric patients
Bettoli, V., Ricci, M., Zauli, S., & Virgili, A. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13951 · Cited by 21
How I Treat Hidradenitis Suppurativa
Kipping, H. (1970) · Postgraduate Medicine · doi:10.1080/00325481.1970.11693572 · Cited by 17
Pyrithione zinc as a general management strategy for hidradenitis suppurativa
Danesh, M. J., & Kimball, A. B. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.07.026 · Cited by 16
Self-citationMonné, C. B., Guerra, S. H., Ortega, C. S., & Quintero, A. B. G. (2014) · Dermatology · doi:10.1159/000365076 · Cited by 15
Bosnić, D., Žarković, B., Barešić, M., Zarkovic, M., & Anić, B. (2016) · Reumatologia/Rheumatology · doi:10.5114/reum.2016.64910 · Cited by 11
Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
Diamantova, D., Lomickova, I., & Cetkovská, P. (2014) · PubMed · Cited by 8
Cited by
Kimball, A. B., Jemec, G. B. E., Alavi, A., Reguiai, Z., Gottlieb, A. B., Bechara, F. G., Paul, C., Giamarellos Bourboulis, E. J., Villani, A. P., Schwinn, A., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00022-3 · Cited by 343
Self-citationHidradenitis Suppurativa: Where We Are and Where We Are Going
Scala, E., Cacciapuoti, S., Garzorz-Stark, N., Megna, M., Marasca, C., Seiringer, P., Volz, T., Eyerich, K., & Fabbrocini, G. (2021) · Cells · doi:10.3390/cells10082094 · Cited by 135
Metadata
- Authors
- Alikhan, A., Sayed, C., Alavi, A., Alhusayen, R., Brassard, A., Burkhart, C., Crowell, K., Eisen, D. B., Gottlieb, A. B., Hamzavi, I., Hazen, P. G., Jaleel, T., Kimball, A. B., Kirby, J., Lowes, M. A., Micheletti, R., Miller, A., Naik, H. B., Orgill, D., & Poulin, Y.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 81
- Issue
- 1
- Pages
- 91-101
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2922238701
- Cited by
- 399
- References
- 78
- FWCI
- 31.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.